Thomas W. Beetham - Insider Trading & Ownership

Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Summary
The estimated net worth of Thomas W. Beetham is at least $1.26M dollars as of March 4, 2025. Thomas W. Beetham is the Chief Operating Officer of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $1.02M. Thomas W. Beetham is the Title: Chief Legal Officer and Secretary of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $239K.
Signature
/s/Jennifer Tousignant, Attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Thomas W. Beetham

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRDN Viridian Therapeutics, Inc.\DE Chief Operating Officer $1.02M Mar 3, 2025
DNTH Dianthus Therapeutics, Inc. /DE/ Title: Chief Legal Officer and Secretary $239K Nov 30, 2022

Insider Transactions Reported by Thomas W. Beetham:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.